Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.
about
Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular eventStatistics review 3: hypothesis testing and P values.Cocaine-associated myocardial infarctionNonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes.Effects of prehospital nitroglycerin on hemodynamics and chest pain intensity.Early interventions in the management of acute uncomplicated myocardial infarction.Early vasodilator treatment in myocardial infarction: appropriate for the majority or minority?Therapeutic options in treating acute myocardial infarction.Headache-type adverse effects of NO donors: vasodilation and beyondMyocardial infarction (ST-elevation).The plasma concentrations of isosorbide 5-mononitrate (5-ISMN) administered in an extended-release form to patients with acute myocardial infarction.Nitric oxide: an emerging role in cardioprotection?Neuronal calcium homeostasis and dysregulation.Recent developments in nitric oxide donor drugs.Meta-analysis and investigation of anti-infective therapies.Caveolin as a potential drug target for cardiovascular protection.Acute myocardial infarction. An updated protocol for thrombolytic therapy.Effects of nitrates on mortality in acute myocardial infarction and in heart failure.Contribution of Hepatitis B to Long-Term Outcome Among Patients With Acute Myocardial Infarction: A Nationwide Study.Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction.Role of antiischemic agents in the management of non-ST elevation acute coronary syndrome (NSTE-ACS).Nitrates and other nitric oxide donors in cardiology: current positioning and perspectives.Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart.In support of nitrate ointment for patients with acute myocardial infarction.Nitroglycerin in the treatment of cocaine associated chest pain--clinical safety and efficacy.Applying the results of large clinical trials in the management of acute myocardial infarction.Nitric oxide and the cardiovascular system.Nitrates in myocardial infarction: influence on infarct size, reperfusion, and ventricular remodelling.Pharmacologic therapy for acute myocardial infarction. Which agent, how much, how soon, how long?Do we still need dipyridamole?Heparin as a therapy for atherosclerosis: preliminary observations on the intrapulmonary administration of low-dose heparin in the morning versus evening gauged by its effect on blood variables.Inhibition of platelet aggregation by transdermal glyceryl trinitrateBritish Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction.Primary and secondary drug treatment of myocardial infarction.Glyceryl trinitrate and platelet aggregation: effects of N-acetyl-cysteine.Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatmentIncrease in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.Human vascular smooth muscle cells inhibit platelet aggregation when incubated with glyceryl trinitrate: evidence for generation of nitric oxide.
P2860
Q24240551-BCFAA829-3FEB-42C0-97C7-0C35974A6AE8Q24798551-E5843210-1827-4ED5-9D59-CA39C655C442Q28379116-94138D94-36BF-40B9-8574-9F1ACEDEC130Q30583012-E7641845-6831-4719-B579-88A4CAE31244Q31431771-CBA8FFA3-90F0-4E36-BEFA-11E60C147959Q33145832-1E3300A6-47B8-438B-B799-4B91082E7995Q33608022-6172560B-F0B2-484E-A60F-6388C8C82748Q33612834-6EF6B64B-59D1-459C-B605-B125FE3E8B85Q33617268-AA049556-6A72-42C1-B6AC-DB33534CC66CQ33812736-62627E25-D7AD-4FC8-89BD-0677D94A38FDQ33866536-8AF3DAA4-E698-46C1-982B-3BA82745E765Q34347358-F879ECB5-EF55-4430-9D83-EF0EF4FC381CQ34371121-F1A6CA6A-E025-491A-B4CA-BB4DB10E4F14Q34624910-1E880B89-48BC-4304-BD32-60EA95ECCE28Q36052815-23B473AE-D75F-47C9-9467-624B1862F122Q36179740-5448A73F-CDC8-4B9D-96A9-9F3FAB5171CFQ36193737-D0E32E78-796D-4021-B912-71419AC26A7DQ36252076-AEBCAD96-2157-491B-A046-B3F182A01CEAQ36332160-8BCE5787-6089-4A58-BE29-59267FE62886Q36566972-E41E126A-1C8A-4DEA-87C4-E757219E1CC6Q36905844-3AB6A8AC-8999-4C0A-9894-A0F85BA2BE05Q37788728-BBF34C69-485A-41BE-B686-2DF31C721B3EQ37963774-2702BE9B-B3B7-4727-9B0F-52F5F44F1131Q38137849-BB373E2E-DD3B-4AD8-8271-DAE3405D3E86Q38364525-29E26BCC-0F4F-48D7-B170-7D665B84051BQ38658707-AD30542C-91BB-4FC4-8AA9-3A3B61F47EFFQ39488428-8F747395-5184-41EF-AFD9-F72ABDACB5C3Q40254689-80DD20AF-BAE8-4A40-94BD-15AF5F41254AQ40685373-8EFE32FA-3D30-429B-86E6-08F481D4EDFCQ41334475-724EAAB9-9872-46DC-9C64-95AD60018EEEQ41653248-8F3C9F17-4CA4-491E-BE89-55C4661A0707Q41760001-7D4B0D9B-012A-450D-B2CA-0BD36EE8790AQ41821849-15FD0DA5-F81E-4B7D-84AD-4C5D7E216109Q41899977-DCAD59D6-EF5D-412C-8EF2-89E5EA079754Q41972247-075AC728-2E73-412B-BD24-CED71793E0E4Q42071440-ED2ADD50-D1DF-46A6-B913-6485871C7FCFQ42117808-DAF74208-D3FC-44EB-B9C9-00CD6333A540Q42332637-2A056525-0083-49B7-A1DC-FA1465641BBCQ42464723-4032EDDC-1803-4452-8B12-C267C19EF23DQ42560973-B1578BBA-85F8-4602-B49B-3DD70851B0E5
P2860
Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Effect of intravenous nitrates ...... view of the randomised trials.
@ast
Effect of intravenous nitrates ...... view of the randomised trials.
@en
Effect of intravenous nitrates ...... view of the randomised trials.
@nl
type
label
Effect of intravenous nitrates ...... view of the randomised trials.
@ast
Effect of intravenous nitrates ...... view of the randomised trials.
@en
Effect of intravenous nitrates ...... view of the randomised trials.
@nl
prefLabel
Effect of intravenous nitrates ...... view of the randomised trials.
@ast
Effect of intravenous nitrates ...... view of the randomised trials.
@en
Effect of intravenous nitrates ...... view of the randomised trials.
@nl
P2093
P1433
P1476
Effect of intravenous nitrates ...... view of the randomised trials.
@en
P2093
P304
P356
10.1016/S0140-6736(88)91906-X
P407
P577
1988-05-01T00:00:00Z